|
HS Code |
944231 |
| Chemical Name | 4-Bromo-2-Iodophenol |
| Molecular Formula | C6H4BrIO |
| Molecular Weight | 313.90 g/mol |
| Cas Number | 67039-16-3 |
| Appearance | Light yellow to beige solid |
| Melting Point | 93-97°C |
| Purity | Typically ≥98% |
| Smiles | C1=CC(=C(C=C1Br)O)I |
| Inchi Key | JVQBIXDGIFOJDK-UHFFFAOYSA-N |
| Solubility | Slightly soluble in water, soluble in organic solvents |
| Storage Conditions | Store at room temperature, in a dry place |
As an accredited 4-Bromo-2-Iodophenol factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | The packaging for 4-Bromo-2-Iodophenol (5 grams) is a sealed amber glass bottle with a tamper-evident screw cap. |
| Shipping | 4-Bromo-2-Iodophenol is shipped in secure, tightly sealed containers compliant with chemical safety regulations. It is packaged to prevent moisture exposure and physical damage. Transport follows hazardous material guidelines, including labeling and documentation, ensuring safe handling and delivery. Expedited or temperature-controlled shipping is available upon request, depending on customer requirements. |
| Storage | 4-Bromo-2-iodophenol should be stored in a tightly sealed container, protected from light and moisture, in a cool, dry, and well-ventilated area. Keep away from incompatible materials such as strong oxidizers and bases. Store at room temperature and clearly labeled to prevent accidental misuse. Use gloves and appropriate personal protective equipment when handling to minimize exposure. |
Competitive 4-Bromo-2-Iodophenol prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615380400285 or mail to sales2@liwei-chem.com.
We will respond to you as soon as possible.
Tel: +8615380400285
Email: sales2@liwei-chem.com
Flexible payment, competitive price, premium service - Inquire now!
Every batch of 4-Bromo-2-Iodophenol (model: 98% min, crystalline) that leaves our reactor started as an idea within our own R&D lab. This compound—often cited as a trusted intermediate for pharmaceuticals, agrochemicals, and advanced materials synthesis—lands in assembly lines and bench-side test tubes across industries for a reason: we take it from concept to crystal in-house. The weight of that responsibility has shaped our approach since we first scaled up halogenated phenol production years ago, and each kilogram reflects our tough internal standards.
Chemists in our circle know that aromatic halogenation is no small feat. Reactions must be tightly controlled to block side reactions that can taint purity or lower yield. There’s a lot on the line, whether you’re pushing for a new active pharmaceutical ingredient or evaluating new material monomers. What drew us to 4-Bromo-2-Iodophenol early on was its unique structure—the ortho arrangement of bromine and iodine creates a rare reactivity profile that can’t be swapped out by tossing in a simpler phenol or a single-halogen derivative.
Down on our shop floor, chemistry is hands-on. Operators and QC staff track progress from the moment we receive the upstream precursors. Skilled synthetic work lets us guide bromination and iodination steps so we avoid off-target halogenation, which would send the process back to square one. We keep all raw materials and solvents traceable, and we've invested in extra purification cycles because even a shadow of an unwanted isomer can send downstream chemistry sideways. HPLC and NMR certificates come standard with every order—not because spec sheets ask for them, but because our client calls always start with “what’s the actual purity this time?” We believe in measurable results, not blanket promises.
What stands out to long-term partners is the consistency across runs. Many buyers who switched to our product found they did not have to tweak reaction protocols to account for different impurity profiles every quarter. A reliable melting point, uniform particle size after milling, and strong batch-to-batch repeatability have given researchers and process engineers a stable foundation to scale their projects.
Our 4-Bromo-2-Iodophenol shows up as off-white to pale yellow crystals. Melting point typically reflects published values—routinely falling between 110°C and 113°C. Not every lab needs ultra-high purity, but even at the 98% level, trace metals and halide residues stay well under 0.2%. Moisture and residual solvents get flagged during QC. Average lot size ranges from 10 kg up to 250 kg, and we routinely scale larger. Because this compound is sometimes hygroscopic, we use low-permeability packaging and double-seal drums to keep it stable during transport and storage.
Chemical compatibility and storage data stem from decades spent watching how these crystals behave—how they interact with plastic, how exposure to ambient light and air affects color or solubility, and what buffers shipment delays. We realized early that temperature swings in transit invite caking and surface degradation, especially during humid months. Shipping under desiccant, with clear batch-dating, helps customers avoid guessing about freshness.
Most interest in this compound comes from colleagues working on coupling chemistry—Suzuki, Sonogashira, and Ullmann reactions. The combination of bromine and iodine gives users precise control over stepwise functionalization. For example, the iodine atom supports a quick and relatively gentle oxidative addition step for palladium catalysts, opening up diverse C–C and C–N coupling routes. Synthesis of biaryl and heterocyclic units—especially for new small-molecule drug leads—gets a lift from this orthogonality. The remaining bromo-substituent can often survive early-stage conditions, ready for selective activation later. People building libraries for SAR work or combinatorial screens often mention the flexibility that comes from having both halides on a single core.
Researchers in agricultural chemistry have told us that the combination of halogens on the phenol gives access to crop-protection intermediates with specific electronic effects—tuning reactivity, persistence, or biological interactions. Material scientists also dip into our catalog to explore new monomers and building blocks for optoelectronic materials, where dual-halogen precursors prove valuable as seeds for further derivatization. Most find that ordinary mono-halogenated phenols don’t quite cut it in terms of reactivity, or forcing those single substitutions to react can increase byproduct rates and purification headaches. Synthesis teams looking for meta- or para-isomers of bromo-iodophenol, or switching bromine and iodine positions, quickly see performance changes: yields, selectivity, and sometimes toxicity or downstream regulation.
In market surveys and direct user calls, many chemists cite a recurring irritation—the opacity of sourcing. Repackagers and non-integrated traders often cannot confirm the synthetic route for their material. Ask about residual metal catalysts or process contaminants, and you begin to hear hedging. As manufacturer, we hold all process data and reference spectra in-house; we can say how each lot was produced, including the precise halogenation order and sequence of purifications. This matters when regulation asks for full chemical traceability or “known providence” under cGMP or ISO conditions. Customers running regulated synthesis—the kind that winds up in clinical trials or on large-acreage field programs—only trust material with a clear provenance trail.
Part of our edge comes from avoiding pooled intermediates from prior runs; each batch is kept distinct, not blended, keeping track of its own process signature. Some buyers discovered unpredictable performance switching between sources—especially as they moved from R&D flask-scale work to pilot or manufacturing scale. We keep up with their scale-up challenges by offering technical support from the same chemists who built the process, avoiding the familiar “please wait while we contact the producer” runaround.
Feedback from buyers pointed to one key difference: purity management. In some supply chains, a claim of 98%+ purity masks a broad range of minor contaminants, especially if the purification only goes as far as what is easily achieved. Our internal protocols chase down side-products to below chromatographic detection, logging every trace we find, because accumulating these over repeated runs can start causing yield dips or unwanted reactions in final step chemistry. After a process review a few years back, we re-engineered purge steps for several solvents to eliminate polar impurities that caused issues in downstream coupling. Nobody wants an impurity profile shifting mid-development.
On the ground, no one benefits from mystery materials or shifting specs. We regularly archive production runs, keeping reference samples for every batch, so that if a user encounters issues, we can trace and diagnose them quickly. Our openness with process documentation is designed to cut risk, not sell a brand story.
Once researchers work with dual halogenated phenols, they rarely go back to single-halide options voluntarily. The reactivity differences are not theoretical. Comparing 4-Bromo-2-Iodophenol with similar mono-halogenated analogues, the combination of bromine and iodine changes more than just the starting point for coupling reactions—it shifts selectivity, reaction rates, solubility in key solvents, and even crystal shape. As opposed to plain 2-iodophenol or 4-bromophenol, the ortho-effect and dual electron-donating/withdrawing nature lets you dial in precise transformations.
Selectivity and step economy improve when templates carry two halogens in well-defined positions. If a procedure tries to rely on late-stage halogenation of a mono-halide to install the second group, side reactions multiply, and control drops. Even minor byproducts in early steps get amplified downstream, resulting in product material that diverges subtly—or obviously—from what a regulatory agency or a final customer expects. Some end-users searching for non-standard isomers or custom substitution patterns find that the ready availability of 4-Bromo-2-Iodophenol simplifies route planning, compared to stitching together more complex halogenations at later points.
Storage considerations shift, too. In our experience, mono-halides like 4-bromophenol or 2-iodophenol tend to show slightly better air stability and lower moisture pick-up, but in the case of our dual-halogen product, improved packaging and regular moisture tests balance that out. The combined presence of Br and I also pushes the material into a melting point window favored by most solid-phase handling equipment—no need to make tradeoffs between solubility and stability.
Every container’s label carries our batch number, with the original NMR, HPLC, and moisture analysis reports attached; we prefer excessive clarity over any “trust us” attitude. We learned from customer feedback on inconsistent raw material lots, which prompted us to move to multi-method analysis: proton and carbon NMR, GC-MS, and titration-based halide quantification. Pharmaceutical and high-value specialty product developers can’t afford analytical ambiguity, so our full analytical package travels with the material. We maintain in-house reference samples from each batch for multi-year retention, allowing us to troubleshoot or confirm long-term stability well after shipping.
Process changes, even subtle ones, carry through into product batches. We keep detailed records of synthetic intermediates, halogen sources, and QA outcomes, not only for regulatory compliance but because it makes a difference to downstream users working under tight quality frameworks. If a client flags a reactivity shift or points out a byproduct, we dig through those records for answers—no excuses, only traceable facts. Sometimes a batch flagged for a shifted melting point, upon inspection, tells us more about equipment wear or solvent drift than any third-party certificate could. Trust is hard-earned in custom chemistry. We live and die by our ability to stand behind process detail.
The hardest stories we’ve heard from our industry partners always revolve around supply interruptions or “stealth” process changes—substituted raw materials, off-spec batches, undetected degradation. Once, a pharmaceutical client reported a reaction that suddenly failed after changing suppliers; forensic testing revealed a non-disclosed twin byproduct due to incomplete halogenation control upstream. To counter situations like this, our own process starts with vetted raw material lots, with full traceability. We do not source upstream halides or phenol intermediates from non-audited suppliers, even if that means increased lead times. The cost of a failed downstream run handily outweighs marginal input savings.
Often, those seeking quicker or cheaper material from non-manufacturing sources later discover that off-standard melting point or solubility differences indicate hidden impurities. For research groups or process engineers, solving production hiccups is easier when the starting material’s history is available. That’s why we store all in-process control data and offer full transparency on requested lots. For regulated industries, open access to the underlying production narrative—including the specific order and timing of halogenations—lets auditors sign-off smoothly.
Investment in stability testing also sets apart consistently performing 4-Bromo-2-Iodophenol. Environmental exposure, even if brief, reshapes impurity profiles that can cause subtle batch-to-batch performance drift. We subject control samples to accelerated aging and keep analytical profiles for cross-comparison, alerting users to optimal handling and storage. Learning from those who ship bulk material globally, we upgraded packaging with double-sealed drums and humidity tracking.
Chemists pushing boundaries in medicinal chemistry, agrochemical synthesis, and advanced materials engineering tell us that confidence in raw material supply removes major headaches. The less time spent troubleshooting upstream, the more focus can go on end product innovation. We fuel their progress not only through stable material, but by supporting custom orders, scale-ups, and route optimization based on feedback and real-world user stories. Our tech support comes from the bench, not the office: the same scientists running pilot batches share their hard-won tips on dissolution, reaction sequences, and post-processing tricks.
Sometimes clients encounter needs for isomeric variants, halogen position switches, or even custom labeling for research or regulatory tracking. Our setup allows direct back-and-forth between user and chemist, solving problems before they hit scale. We’ve also fielded customer-led improvement requests, like smaller lot production for rapid screening or special QC regimens for high-sensitivity applications.
Our role as a manufacturer goes deeper than delivering a flask or a drum; it’s about partnership in progress. 4-Bromo-2-Iodophenol, in its highly specified form, continues to enable breakthroughs in synthesis and application. Each specification, procedural detail, and quality checkpoint is based not on market demand but on cumulative, day-to-day chemical practice. Where standards shift or new applications emerge, we adapt, drawing on our on-the-ground perspective to tweak and refine quality and service. Hunger for true-to-spec intermediates keeps our benches busy—and our focus fixed on getting every batch right, with full transparency and a respect for the process that never blinks.